Celldex Therapeutics, Inc. (CLDX) key performance indicators and operating metrics (4 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Product development and licensing revenue | 7K | FY2026-Q2 |
| Contract and grant revenue | 645K | FY2025-Q1 |
| Service revenue | 7K | FY2026-Q2 |
| Grant revenue | 723K | FY2025-Q2 |
Back to CLDX overview · CLDX earnings · CLDX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.